Skip to main content
Luoxin Pharmaceuticals Group Stock Co., Ltd. logo

Luoxin Pharmaceuticals Group Stock Co., Ltd. — Investor Relations & Filings

Ticker · 002793 ISIN · CNE1000026S7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,601 across all filing types
Latest filing 2025-12-01 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002793

About Luoxin Pharmaceuticals Group Stock Co., Ltd.

https://www.luoxin.cn

Luoxin Pharmaceuticals Group Stock Co., Ltd. focuses on the research, development, manufacturing, and distribution of diverse medicinal products. The company specializes in therapeutic areas including digestive health, respiratory medicine, anti-infectives, and oncology. Its portfolio includes various formulations such as injections, tablets, and capsules, with a notable emphasis on proton pump inhibitors and respiratory treatments. Luoxin operates a vertically integrated model, producing both active pharmaceutical ingredients (APIs) and finished dosage forms. The organization emphasizes innovation through dedicated R&D facilities to develop high-quality healthcare solutions. Its operations are supported by a comprehensive supply chain and manufacturing infrastructure designed to adhere to international quality standards, serving broad market segments with a focus on clinical efficacy and patient accessibility.

Recent filings

Filing Released Lang Actions
第五届董事会第三十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 33rd meeting of the 5th Board of Directors of Luoxin Pharmaceutical Group Co., Ltd. It details the meeting date, attendance, and the approval of an employee stock ownership plan adjustment. There is no financial data or comprehensive report content, but rather a formal announcement of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management. The document length is short and it is clearly a meeting resolution announcement, not a full report or financial statement.
2025-12-01 Chinese
关于2024年员工持股计划实施的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress and adjustments of the company's 2024 employee stock ownership plan. It details board meetings and decisions related to the plan's implementation and share allocation. The document is short (1021 characters) and serves as a progress update or announcement rather than a full report or financial statement. It does not contain financial results, audit information, or detailed financial data. It is not a report publication announcement since it provides substantive update information. The content fits best under Capital/Financing Update (CAP) as it relates to employee stock ownership plan implementation and share allocation adjustments.
2025-12-01 Chinese
关于2024年员工持股计划首次授予部分第一个锁定期届满暨解锁条件成就的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expiration of the first lock-up period and the achievement of unlocking conditions for the company's 2024 employee stock ownership plan. It details the approval procedures, performance targets, and subsequent arrangements related to the employee stock plan. The content focuses on employee stock plan updates, approvals, and unlocking conditions rather than financial results, earnings, or management changes. It is not a full financial report, earnings release, or management report. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement about the employee stock ownership plan status and related corporate governance matters. Therefore, the most appropriate classification is a Regulatory Filing (RNS), as it is a regulatory announcement that does not fit into more specific categories like remuneration information or capital changes.
2025-12-01 Chinese
关于为控股子公司提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of providing guarantees for a controlling subsidiary by the company. It includes details about the guarantee amount, contractual terms, board approvals, and financial data of the subsidiary. The document is relatively short (2589 characters) and focuses on a specific financing-related update rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed management analysis. The content aligns with updates on financing activities or capital structure changes, specifically guarantees provided to subsidiaries. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2025-11-28 Chinese
北京市金杜律师事务所上海分所关于罗欣药业集团股份有限公司2025年第六次临时股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and voting results of a company's 2025 sixth extraordinary shareholders meeting. It details the legal compliance of the meeting's call, attendance, voting procedures, and results. The document is not a financial report, earnings release, or management discussion, but rather a legal certification and confirmation of the shareholder meeting process and outcomes. It includes detailed voting results and legal opinions on the meeting's validity. This type of document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders meeting and confirms their legality and validity.
2025-11-14 Chinese
2025年第六次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 sixth extraordinary general meeting (临时股东会) of Luoxin Pharmaceutical Group Co., Ltd. It includes information about the meeting's convocation, attendance, voting results on various proposals including amendments to the company charter, election of directors, and approval of a private placement of A shares. The document also contains legal opinions confirming the legality of the meeting and voting process. This is not a full annual or interim report, nor is it a simple announcement of voting results. It is a formal disclosure of the shareholder meeting resolutions and voting outcomes, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (7642 characters) and detailed voting data support this classification rather than a brief announcement or a proxy solicitation. Therefore, the filing type is DVA with high confidence.
2025-11-14 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.